MARTHA STOOPS: Open Payments
NPI 1235765496 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 63 payments from 16 companies in 2025. Trend: 2023 $1,138 · 2024 $1,588 · 2025 $1,748
Food & beverage: $1,748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $660 |
| Ardelyx, Inc. | 8 | $338 |
| Ipsen Biopharmaceuticals, Inc | 2 | $145 |
| Madrigal Pharmaceuticals | 2 | $102 |
| Janssen Biotech, Inc. | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| PFIZER INC. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Celltrion USA Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: IBSRELA, SKYRIZI, RINVOQ, IQIRVO, REZDIFFRA, TREMFYA, ENTYVIO, DUPIXENT.
Industry payments across VA — which companies pay providers there.
